Literature DB >> 31911796

Electrical cardioversion for supraventricular arrhythmias in octagenarians.

Felipe L Malafaia1, Patrícia O Guimarães1, Márcio C Sampaio1, Pedro G M de Barros E Silva1, Renato D Lopes2, Juliano V Custódio1, Miguel da S Diniz1, José C T Garcia1, Valter Furlan1.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Electrical cardioversion; Octagenarians

Year:  2019        PMID： 31911796      PMCID： PMC6938742          DOI： 10.11909/j.issn.1671-5411.2019.12.009

Source DB:  PubMed          Journal:  J Geriatr Cardiol        ISSN： 1671-5411            Impact factor:   3.327


× No keyword cloud information.
  10 in total

1.  Propofol Use in the Elderly Population: Prevalence of Overdose and Association With 30-Day Mortality.

Authors:  Adam T Phillips; Stacie Deiner; Hung Mo Lin; Evie Andreopoulos; Jeffrey Silverstein; Matthew A Levin
Journal:  Clin Ther       Date:  2015-11-06       Impact factor: 3.393

2.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2019-01-28       Impact factor: 24.094

3.  Effects of dabigatran according to age in atrial fibrillation.

Authors:  Mandy N Lauw; John W Eikelboom; Michiel Coppens; Lars Wallentin; Salim Yusuf; Michael Ezekowitz; Jonas Oldgren; Juliet Nakamya; Jia Wang; Stuart J Connolly
Journal:  Heart       Date:  2017-02-17       Impact factor: 5.994

4.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

5.  Procedural sedation with propofol for emergency DC cardioversion.

Authors:  Philip Kaye; Matthew Govier
Journal:  Emerg Med J       Date:  2013-07-29       Impact factor: 2.740

6.  Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Authors:  Jonathan L Halperin; Graeme J Hankey; Daniel M Wojdyla; Jonathan P Piccini; Yuliya Lokhnygina; Manesh R Patel; Günter Breithardt; Daniel E Singer; Richard C Becker; Werner Hacke; John F Paolini; Christopher C Nessel; Kenneth W Mahaffey; Robert M Califf; Keith A A Fox
Journal:  Circulation       Date:  2014-06-03       Impact factor: 29.690

7.  Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

Authors:  Sigrun Halvorsen; Dan Atar; Hongqiu Yang; Raffaele De Caterina; Cetin Erol; David Garcia; Christopher B Granger; Michael Hanna; Claes Held; Steen Husted; Elaine M Hylek; Petr Jansky; Renato D Lopes; Witold Ruzyllo; Laine Thomas; Lars Wallentin
Journal:  Eur Heart J       Date:  2014-02-20       Impact factor: 29.983

8.  Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study.

Authors:  Gabriel S C Yiin; Dominic P J Howard; Nicola L M Paul; Linxin Li; Ramon Luengo-Fernandez; Linda M Bull; Sarah J V Welch; Sergei A Gutnikov; Ziyah Mehta; Peter M Rothwell
Journal:  Circulation       Date:  2014-09-10       Impact factor: 29.690

9.  Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.

Authors:  Eri Toda Kato; Robert P Giugliano; Christian T Ruff; Yukihiro Koretsune; Takeshi Yamashita; Robert Gabor Kiss; Francesco Nordio; Sabina A Murphy; Tetsuya Kimura; James Jin; Hans Lanz; Michele Mercuri; Eugene Braunwald; Elliott M Antman
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

10.  Atrial fibrillation after electrical cardioversion in elderly patients: a role for arterial stiffness? Results from a preliminary study.

Authors:  Stefano Fumagalli; Ilaria Giannini; Simone Pupo; Francesca Agostini; Serena Boni; Anna T Roberts; Debbie Gabbai; Claudia Di Serio; Luciano Gabbani; Francesca Tarantini; Niccolò Marchionni
Journal:  Aging Clin Exp Res       Date:  2016-08-27       Impact factor: 3.636
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.